Ocular Therapeutix
OCUL
OCUL
116 hedge funds and large institutions have $111M invested in Ocular Therapeutix in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less capital invested
Capital invested by funds: $178M → $111M (-$66.9M)
52% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 25
Holders
116
Holding in Top 10
2
Calls
$788K
Puts
$703K
Top Buyers
| 1 | +$1.56M | |
| 2 | +$887K | |
| 3 | +$784K | |
| 4 |
Morgan Stanley
New York
|
+$673K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$519K |
Top Sellers
| 1 | -$2.25M | |
| 2 | -$2.21M | |
| 3 | -$2.15M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$1.52M |
| 5 |
DAM
Deltec Asset Management
New York
|
-$1.32M |